
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html;charset=gbk"/>
<meta name="google-site-verification" content="3SzaxffnKOqXzqzFSmKGYVL4Dz9oEep2l_t38QsRZVM" />
<meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" />
<title>国内药企投身双抗药物研发，2家企业再传新进展_行业动态_柿子网</title>
<meta name="keywords" content="国内药企投身双抗药物研发，2家企业再传新进展,国内药企投身双抗药物研发，2家企业再传新进展,双抗药物,行业动态"/>
<meta name="description" content="国内药企投身双抗药物研发，2家企业再传新进展"/>
<link rel="stylesheet" type="text/css" href="http://www.yaoshang68.com/skin/default/style.css"/>
<![endif]-->
</head>
<body>
<div class="head" id="head">
</div>
<div class="m head_s" id="destoon_space"></div>
<div class="m"><div id="search_tips" style="display:none;"></div></div>
<div class="m">
<div id="search_module" style="display:none;" onmouseout="Dh('search_module');" onmouseover="Ds('search_module');">
<a href="javascript:void(0);" onclick="setModule('5','供应')">供应</a><a href="javascript:void(0);" onclick="setModule('6','求购')">求购</a><a href="javascript:void(0);" onclick="setModule('23','合作')">合作</a><a href="javascript:void(0);" onclick="setModule('24','转让')">转让</a><a href="javascript:void(0);" onclick="setModule('22','招商')">招商</a><a href="javascript:void(0);" onclick="setModule('25','代理')">代理</a><a href="javascript:void(0);" onclick="setModule('8','展会')">展会</a><a href="javascript:void(0);" onclick="setModule('31','网刊')">网刊</a><a href="javascript:void(0);" onclick="setModule('4','企业')">企业</a><a href="javascript:void(0);" onclick="setModule('21','资讯')">资讯</a></div>
</div>
<div class="m">
<div class="logo f_l"><a href="http://www.yaoshang68.com/"><img src="http://www.yaoshang68.com/skin/default/image/logo.gif" alt="中国药商68网"/></a></div>
<a href="https://reg.cphi-china.cn/zh-cn/user/register?utm_source=media&utm_medium=referral&utm_campaign=banneryaoshanghome" target="_blank"><img src="http://www.yaoshang68.com/file/upload/202209/29/15-32-59-57-1.gif" width="468" height="60" alt=""/></a></div>
<div class="m b10">&nbsp;</div>
<div class="m">
<div class="menu">
<ul><li><a href="http://www.yaoshang68.com/"><span>首页</span></a></li><li><a href="http://www.yaoshang68.com/sell/"><span>供应</span></a></li><li><a href="http://www.yaoshang68.com/buy/"><span>求购</span></a></li><li><a href="http://www.yaoshang68.com/hezuo/"><span>合作</span></a></li><li><a href="http://www.yaoshang68.com/zhuanrang/"><span>转让</span></a></li><li><a href="http://www.yaoshang68.com/invest/"><span>招商</span></a></li><li><a href="http://www.yaoshang68.com/daili/"><span>代理</span></a></li><li><a href="http://www.yaoshang68.com/exhibit/"><span>展会</span></a></li><li><a href="http://www.yaoshang68.com/yswk/"><span>网刊</span></a></li><li><a href="http://www.yaoshang68.com/company/"><span>企业</span></a></li><li class="menuon"><a href="http://www.yaoshang68.com/news/"><span>资讯</span></a></li><li><a href="/extend/5.html"><span>服务</span></a></li><li><a href="/extend/about.html" target="_blank"><span>国际注册与认证</span></a></li><li><a href="http://cas.yaoshang68.com/"><span style="color:#FFFF00;">CAS号</span></a></li><li><a href="http://www.cphibiz.com" target="_blank"><span style="color:#FFFF00;">English</span></a></li></ul>
</div>
</div>
<div class="m">
<form id="destoon_search" action="http://www.yaoshang68.com/news/search.php" onsubmit="return Dsearch(1);">
<input type="hidden" name="moduleid" value="21" id="destoon_moduleid"/>
<input type="hidden" name="spread" value="0" id="destoon_spread"/>
<div class="head_search" onmouseover="this.className='head_search_on';" onmouseout="this.className='head_search';">
<div>
<input name="kw" id="destoon_kw" type="text" class="search_i" value="请输入关键词或CAS号" onfocus="if(this.value=='请输入关键词或CAS号') this.value='';" onkeyup="STip(this.value);" autocomplete="off" x-webkit-speech speech/><input type="text" id="destoon_select" class="search_m" value="资讯" readonly onfocus="this.blur();" onclick="$('#search_module').fadeIn('fast');"/><input type="submit" value=" " class="search_s"/>
</div>
</div>
</form>      
<div class="head_search_kw f_l"><a href="" onclick="Dsearch_top();return false;"><strong>标王</strong></a> 
<a href="" onclick="Dsearch_adv();return false;"><strong>热搜：</strong></a>
<span id="destoon_word"><a href="http://www.yaoshang68.com/news/search.php?kw=%D5%E3%BD%AD" class="b" rel="nofollow">浙江</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%D1%CE%CB%E1" class="b" rel="nofollow">盐酸</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%B0%D7%DE%BC%C2%AB%B4%BC" class="b" rel="nofollow">白藜芦醇</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%B0%B1%BB%F9" class="b" rel="nofollow">氨基</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%BC%BC%CA%F5" class="b" rel="nofollow">技术</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%DF%C1%B8%F1%C1%D0%CD%AA" class="b" rel="nofollow">吡格列酮</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%DF%C1%E0%A4" class="b" rel="nofollow">吡啶</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%D6%D0%BC%E4%CC%E5" class="b" rel="nofollow">中间体</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%D6%C6%D2%A9%C9%E8%B1%B8" class="b" rel="nofollow">制药设备</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%D4%AD%C1%CF%D2%A9" class="b" rel="nofollow">原料药</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%B9%C7%BF%C6" class="b" rel="nofollow">骨科</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%C7%B0%BE%B0%B9%E3%C0%AB" class="b" rel="nofollow">前景广阔</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%CA%D4%BC%C1" class="b" rel="nofollow">试剂</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%D6%D0%B3%C9%D2%A9%A1%B0%B1%DC%B7%E7%B8%DB%A1%B1%BB%F2%B2%BD%C6%E4%BA%F3%B3%BE" class="b" rel="nofollow">中成药“避风港”或步其后尘</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%CE%E4%BA%BA" class="b" rel="nofollow">武汉</a>&nbsp; <a href="http://www.yaoshang68.com/news/search.php?kw=%BB%FA%B9%B9%C7%C4%C7%C4%C7%B1%B7%FC%A1%B0%B4%B4%D0%C2%D2%A9%A1%B1" class="b" rel="nofollow">机构悄悄潜伏“创新药”</a>&nbsp; </span></div>
</div>
<div class="m b10">&nbsp;</div><script src="http://cpro.baidustatic.com/cpro/ui/c.js" type="text/javascript"></script>
<script type="text/javascript">var module_id= 21,item_id=100983,content_id='content',img_max_width=640;</script>
</div>
<div class="m">
<div class="m_l f_l">
<div class="left_box">
<div class="pos">当前位置: <a href="http://www.yaoshang68.com/">首页</a> &raquo; <a href="http://www.yaoshang68.com/news/">资讯</a> &raquo; <a href="http://www.yaoshang68.com/news/list-763.html">行业动态</a> &raquo; 正文</div>
<h1 class="title" id="title">国内药企投身双抗药物研发，2家企业再传新进展</h1>
<div class="info"><span class="f_r"><img src="http://www.yaoshang68.com/skin/default/image/zoomin.gif" width="16" height="16" alt="放大字体" class="c_p" onclick="fontZoom('+', 'article');"/>&nbsp;&nbsp;<img src="http://www.yaoshang68.com/skin/default/image/zoomout.gif" width="16" height="16"  alt="缩小字体" class="c_p" onclick="fontZoom('-', 'article');"/></span>
发布日期：2022-11-07&nbsp;&nbsp;浏览次数：<span id="hits">20</span>
</div>
<div id="content">
<div class="content" id="article">在全球双抗药物研发浪潮涌动的背景下，国内企业也有一批企业投身双抗药物的研发。笔者获悉，近期又有多家药企在双抗药物研发上取得新进展。<br />&nbsp;</div><div>　　如11月2日，安科生物发布公告显示，公司与控股子公司合肥瀚科迈博生物技术有限公司共同申报的PD-L1/4-1BB双特异性抗体&ldquo;HK010注射液&rdquo;临床试验申请已获批准。<br />&nbsp;</div><div>　　而11月1日，国家药品监督管理局药品审评中心网公示显示，康方生物申报的AK129注射液临床试验申请获得默示许可，该创新药是LAG-3(淋巴细胞活化基因3)/PD-1(程序性死亡蛋白1)双抗，拟开发用于治疗晚期恶性肿瘤。<br />&nbsp;</div><div>　　据安科生物表示，HK010注射液是公司拥有自主知识产权的新型PD-L1/4-1BB双特异性抗体，拟定适应症为晚期恶性肿瘤。据了解，PD-L1/4-1BB的双特异性抗体HK010既能阻断免疫抑制性的PD-L1/PD-1，又条件性激活4-1BB共刺激信号，从而达到解除免疫抑制和激活免疫系统的双重作用，在增强药效的同时提高安全性，是一款具有潜力的抗肿瘤双特异性抗体。目前，国内外尚无PD-L1/4-1BB双特异性抗体上市，相关产品在国内外均处于临床研究阶段。<br />&nbsp;</div><div>　　而康方生物在2022年美国癌症研究协会(AACR)年会上，公布了AK129的临床前研究结果。数据显示：与PD-1抗体和LAG-3抗体联合疗法相比，AK129可介导更强的免疫激活；AK129不仅具有良好的抗原结合性，有效阻滞PD-1/LAG-3信号通路，还可促进外周血单个核细胞(PBMC)中IL-2和IFN-&gamma;产生；此外，AK129在动物实验中也显示了良好的抗肿瘤活性。<br />&nbsp;</div><div>　　所谓双抗，是指能同时特异性结合两个抗原或抗原表位的人工抗体。与普通单克隆抗体相比，双特异性抗体具有同时结合两种特异性表位或目的蛋白的功能，因此可以发挥特殊的功能起到单抗药物难以达到的生物学功能。<br />&nbsp;</div><div>　　近年来全球双抗药物研发浪潮涌动。数据显示，2022年以来，双抗药物密集获批，截至9月12日，全球已有4款药物获批上市，另有2款药物已提交上市申请，有望近期获批上市。在全球市场的涌动下，我国也也有一批企业开始投身双抗药物的研发。如国内企业中北京天广实、科伦药业、正大天晴、复宏汉霖、恒瑞医药、信达生物、再生元制药、时迈药业、誉衡药业等众多企业也正在布局双抗药物新药。<br />&nbsp;</div><div>　　其中，康方生物的卡度尼利是头一款获批上市的国产双抗药物，于今年6月份获批。此外，康方生物的凯得宁单抗(AK104)已于2021年9月向NMPA递交了用于治疗复发或难治性宫颈癌的上市申请，有望率先上市。<br />&nbsp;</div><div>　　分析人士指出，随着技术平台的日益成熟，获批药物种类将日渐增多，国内双抗药物市场规模或高速扩张。据预测，到2030年，这一市场有望达到108亿美元，2022年至2030年复合增长率达81.7%。<br />&nbsp;</div><div>　　但是相比较单克隆抗体，双特异性抗体研发仍处于早期快速发展阶段，产品的市场竞争格局尚不明确，企业研发竞争尚不充分。业内表示，受技术壁垒影响，掌握相关技术平台的企业或将脱颖而出，成为未来双特异性抗体领域的代表企业。<br />&nbsp;</div><div>　　免责声明：在任何情况下，本文中的信息或表述的意见，均不构成对任何人的投资建议。</div>
<div class="bdsharebuttonbox" id="content"><a href="#" class="bds_more" data-cmd="more"></a><a href="#" class="bds_weixin" data-cmd="weixin" title="分享到微信"></a><a href="#" class="bds_sqq" data-cmd="sqq" title="分享到QQ好友"></a><a href="#" class="bds_qzone" data-cmd="qzone" title="分享到QQ空间"></a><a href="#" class="bds_tsina" data-cmd="tsina" title="分享到新浪微博"></a><a href="#" class="bds_tqq" data-cmd="tqq" title="分享到腾讯微博"></a><a href="#" class="bds_tsohu" data-cmd="tsohu" title="分享到搜狐微博"></a><a href="#" class="bds_tieba" data-cmd="tieba" title="分享到百度贴吧"></a><a href="#" class="bds_renren" data-cmd="renren" title="分享到人人网"></a><a href="#" class="bds_youdao" data-cmd="youdao" title="分享到有道云笔记"></a><a href="#" class="bds_fx" data-cmd="fx" title="分享到飞信"></a><a href="#" class="bds_ty" data-cmd="ty" title="分享到天涯社区"></a><a href="#" class="bds_fbook" data-cmd="fbook" title="分享到Facebook"></a><a href="#" class="bds_twi" data-cmd="twi" title="分享到Twitter"></a><a href="#" class="bds_copy" data-cmd="copy" title="分享到复制网址"></a><a href="#" class="bds_print" data-cmd="print" title="分享到打印"></a></div>
<script>window._bd_share_config={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"分享到：","viewSize":"24"},"selectShare":{"bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}};with(document)0[(getElementsByTagName('head')[0]||body).appendChild(createElement('script')).src='http://bdimg.share.baidu.com/static/api/js/share.js?v=89860593.js?cdnversion='+~(-new Date()/36e5)];</script>
</div>
<div class="b10 c_b">&nbsp;</div>
<div class="keytags">
<strong>关键词：</strong>
<a href="http://www.yaoshang68.com/news/search.php?kw=%B9%FA%C4%DA%D2%A9%C6%F3%CD%B6%C9%ED%CB%AB%BF%B9%D2%A9%CE%EF%D1%D0%B7%A2%A3%AC2%BC%D2%C6%F3%D2%B5%D4%D9%B4%AB%D0%C2%BD%F8%D5%B9%2C%CB%AB%BF%B9%D2%A9%CE%EF" target="_blank" rel="nofollow">国内药企投身双抗药物研发，2家企业再传新进展,双抗药物</a>
</div>
<div class="np">
<ul>
<li><strong>下一篇：</strong><a href="http://www.yaoshang68.com/news/show-100984.html" title="医药板块异动，众生药业、灵康药业等多只个股涨停">医药板块异动，众生药业、灵康药业等多只个股涨停</a>
</li>
<li><strong>上一篇：</strong><a href="http://www.yaoshang68.com/news/show-100982.html" title="进入冬季，制药纯化水设备可能出现的问题以及应对方法">进入冬季，制药纯化水设备可能出现的问题以及应对方法</a>
</li>
</ul>
</div>
</body>
</html>
